The aim of this paper was to evaluate physical stability of solid dispersions in respect to the drug, tadalafil (Td), in vinylpyrrolidone and vinyl acetate block copolymer (PVP-VA). Nine solid dispersions of Td in PVP-VA (Td/PVP-VA) varied in terms of quantitative composition (1:9-9:1, w/w) were successfully produced by spray-drying. Their amorphous nature, supersaturated character and molecular level of mixing (a solid solution structure) were subsequently confirmed using DSC, PXRD, SEM and calculation of Hansen total solubility parameters. Due to thermal degradation of both components before the melting point of Td 
Introduction
The number of poorly soluble drug substances available on the global pharmaceutical market has been growing constantly for last decades. Hence, many approaches aimed at improving apparent solubility and increasing dissolution rates have been developed [5, 21] . Formation of solid dispersions is one of the most promising approaches due to its high effectiveness, flexibility in designing the composition and up-to-date devices adapted for their production [4, 20] . In general, solid dispersions can be defined as at least two-component systems of a drug substance usually dispersed in a polymeric matrix but in fact they may be more diverse in their composition [11] . The unique morphology of solid dispersions frequently leads to water solubility enhancement, which can be explained by improved wettability, amorphization and size reduction of drug particles [21] .
Despite many advantages and the fact that solid dispersions have been known for the last 40 years, only a few of them have been introduced as commercial products to date [3] . The main reason of this lies in their physical instability, which may lead to changes in dissolution profiles and, as a consequence, in bioavailability [8] . Solid dispersions are preferably amorphous systems where the drug substance is molecularly dispersed in an inherently amorphous polymer. The initial drug loading may be boundlessly high but from the thermodynamic point of view only the amount not exceeding its intrinsic solubility in a polymer does not tend to crystallize [13] . This gives an advantage over amorphous drugs without excipients, which are always high energy and therefore highly physically unstable structures. Crystallization can be considered as a kinetically driven process depending on mobility of molecules but thermodynamic properties resulting from the drug content and its solubility in the polymer are thought to be the key parameters regarding physical stability of solid dispersions [13, 15] .
Considering the above, the aim of this paper was to evaluate the physical stability of supersaturated and undersaturated solid dispersions in respect to the drug, tadalafil (Td), in vinylpyrrolidone and vinyl acetate block copolymer (PVP-VA). The drug and polymer were selected based on our previous study in which aqueous solubility and the dissolution rate of Td were significantly improved by its incorporation in the PVP-VA matrix [23] . An interesting aspect of the current work is that the glass transition temperature (Tg) of the polymer (107. 4 °C) is lower than that of pure amorphous Td (149.9 °C). Since it is deemed that the stabilizing effect on the amorphous drug is mainly the result of its Tg increase and molecular mobility decrease in a solid dispersion [9, 10] , investigating properties of a system with the reverse trend in Tgs may contribute to a better understanding of stabilization mechanisms.
Based on the previous data [22] on the thermal degradation of Td and PVP-VA before reaching the melting point of the drug it was paramount to select an appropriate method to determine thermodynamic solubility of Td in PVP-VA at 25 °C, which is the most common temperature of drug storage. It is important as to date all described methods of solubility determination are based on measurements at temperatures above Tg of the polymer and one of the most common protocols known as "the melting point depression method" utilizes the decrease of the drug melting temperature in a physical mixture [13] . Apart from thermal degradation, the biggest drawback of this method is the risk of solubility underestimation caused by low molecular mobility in a viscous polymer and an inadequate shift of the endotherm. Modifications involving initial milling of physical mixtures, annealing and different heating rates improve the protocol but significantly extend the analysis [18, 17] .
Another, a slightly modified approach based on the melting point depression principle, which also could not be utilized in this work, is based on the measurement of the drug melting enthalpy reduction in a physical mixture [1] . In this method a crystalline drug dissolves in a polymer at a pre-set constant temperature and is subsequently heated up to the drug melting point to determine its enthalpy of fusion. The analysis of physical mixtures prepared in different weight ratios enables to extrapolate the enthalpy curve to "the zero melting enthalpy" point which indicates the complete dissolution of a drug in a polymer and thereby the thermodynamic solubility at a given temperature of dissolving. Finally, by repeating this step at different dissolving temperatures one can obtain the solubility change as a function of temperature.
Thus, to determine solubility of Td in PVP-VA considering thermal degradation of components, an innovative protocol described by Mahieu and coworkers was selected [12] .
The general principle of this approach employs drug crystallization from a supersaturated solid dispersion, which takes place above its Tg. As a consequence, a thermodynamically stable solid dispersion is formed, of which Tg gives the information about its new quantitative composition.
To support this approach, another method of drug solubility in the polymer, based on a fast heating rate, was investigated. This experimental protocol utilized an annealing step whereby physical mixtures of crystalline Td and PVP-VA were equilibrated at a chosen temperature above the Tg of the polymer and subsequently the melting point of the drug was determined applying a heating rate of 200 °C/min. It has been established that thermal decomposition of pharmaceutical substances can be minimized when using sufficiently fast heating rates [14] .
The duration of the annealing step was optimized to allow the drug to dissolve in the amorphous polymer, similar to the treatment used by Sun et al. [17] . Solid dispersions of Td in PVP-VA (Td/PVP-VA) in this investigation were produced by spray-drying. Finally, they were subjected to accelerated aging tests, the results of which were juxtaposed with the calculated solubility of Td in PVP-VA and hot stage polarized light microscopy experiments.
Materials and methods

Materials
Tadalafil (Td) (series 20211) as well as vinylpyrrolidone and vinyl acetate block copolymer (Kollidon VA 64, PVP-VA) were kindly donated by Polpharma S.A. (Poland) and BASF SE (Germany), respectively. Ultrapure water was produced by Millipore Direct-Q 3UV-R water purification system. Acetone and all other chemicals of analytical grade were purchased from Sigma-Aldrich (Germany).
Methods
Preparation of samples
2.2.1.1. Preparation of tadalafil solid dispersions using spray drying Td/PVP-VA solid dispersions were obtained by spray drying of solutions (acetone/water 9:1, v/v) containing Td and PVP-VA in a range of weight ratios (1:9-9:1 w/w in 10% increments).
The total concentration of solids in solutions was 1% (w/v). The process was performed in a Mini Spray Dryer B-290 (Büchi, Switzerland) using an open, suction mode with nitrogen. The gas inlet pressure was 6 bar and set to 4 cm of the gas flow (rotameter setting). Spray dryer was equipped with a standard atomization nozzle with a 1.5-mm cap and a 0.7-mm tip. The pump speed was set to 25% (7 ml/min) and the aspirator was operated at 100%. The inlet temperature was set to 65 °C and such setup resulted in an outlet temperature of 52 °C. Additionally, Td 1% (w/v) solution (acetone/water 9:1, v/v) was spray dried following the above procedure.
Preparation of tadalafil physical mixtures
The equivalent physical mixtures (comprising PVP-VA and crystalline Td in the same proportions as those used for spray drying) were prepared by milling in a planetary ball mill PM 100 (Retsch, Germany) at 400 RPM for 10 min. A quantity of 2 g of powder was loaded to the stainless steel container, which had a volume of 50 ml, and three stainless steel balls (20 mm Hansen total solubility parameter (δt) of Td and PVP-VA was calculated based on the group contribution method developed by van Krevelen and co-workers [19] . This approach utilizes the molecular density of energies coming from dispersion (δd), dipolar (δp) and hydrogen forces (δh) according to Eq. (1):
A small difference in total solubility parameters between two compounds (Δδt < 7 MPa 0.5 )
indicates that their miscibility is likely to occur [6] .
Physicochemical analysis of tadalafil solid dispersions
Powder X-ray diffraction (PXRD) analysis
X-ray analysis of samples was made using a desktop powder diffractometer MiniFlexII (Rigaku, Japan), equipped with a Cu Kα radiation X-ray source operated under a voltage of 30 kV and current of 15 mA. The samples were placed on a low-background silicon holder and scanned at room temperature over a 2θ range of 5-40° at a step size of 0.05°/s.
Thermogravimetric analysis (TGA)
Thermal stability of Td and PVP-VA under heating conditions used in DSC analysis (Section Degradation of Td and PVP-VA was determined by the weight loss percentage of the sample.
True density of powders
The true density of PVP-VA and spray dried Td was measured by an AccuPyc 1330
Pycnometer (Micromeritics®) using helium to determine the volume of the sample. A 1 cm 3 sample cup was used.
Scanning electron microscopy (SEM) analysis
Morphological assessment of Td solid dispersions in PVP-VA (5:5, w/w) was carried out on a Supra variable Pressure Field Emission Scanning Electron Microscope (Zeiss, Germany)
equipped with a secondary electron detector and accelerating voltage of 5 kV. A small amount of powder was placed directly on the aluminum stub covered with a carbon tab and excess of powder was removed using a nitrogen purge. The samples were sputter coated with gold/palladium under vacuum before analysis.
Hot stage optical and polarized light microscopy (HS PLM)
Optical and polarized light microscopy was performed with an Olympus BX53 polarizing optical microscope equipped with a U-POT cross polarizer, a Q IMAGING Fast 1394 camera and a Linkam LTS 420 hotstage. Samples were spread evenly on a glass slide and heated at a 5 °C/min rate.
Accelerated aging tests
To examine physical stability, all solid dispersions and neat amorphous Td were subjected to the following aging conditions: 25 °C and 75% RH; 40 °C and 0% RH; 40 °C and 75% RH;
80 °C and 0% RH and 130 °C and 0% RH. The presence of crystalline Td was investigated after pre-set time intervals using PXRD.
Results and discussion
Calculation of tadalafil thermodynamic solubility in a polymer
Physicochemical analysis of tadalafil solid dispersions
Utilization of solid dispersions instead of physical mixtures in the evaluation of drug-polymer solubility is one of the features that distinguishes this method from other commonly used, based on melting point depression [18, 17] . However, the applicability of this approach depends strongly on the type of a solid dispersion which must reveal an amorphous and supersaturated character and good miscibility between components at the molecular level.
In this work a range of Td/PVP-VA solid dispersions with nine different weight ratios was successfully obtained by spray-drying, in contrast to Mahieu and coworkers who used ball milling [12] . The same drying conditions were also used for Td solution without excipients. As indicated by the disappearance of Bragg peaks characteristic of crystalline Td, PXRD revealed the amorphous nature of all solid dispersions and spray dried Td (Fig. 1) . What is crucial for further analysis, inherently amorphous PVP-VA did not mask peaks of crystalline Td in any of the corresponding physical mixtures and the X-ray diffraction pattern of the sample containing the least amount of the drug (1:9, w/w) is presented in Fig. 1 . The lack of Bragg peaks was not the result of the particle size reduction to the order of nanometers which might result in a decrease in the intensity of peaks. As depicted in Fig. 2 , the particles were typical of spray dried material and were round-shaped and micrometer-sized. and 3b). In the thermogram of the latter system there is a Tg with a midpoint at 149.9 °C, followed by an exothermic event with an onset at 181.6 °C and an endothermic sharp peak at 302.1 °C. Melting of crystalline Td, which starts at 302.3 °C, indicates that the exotherm refers to sample crystallization. The occurrence of crystallization during heating of the amorphous sample places Td in the group II of the glass-forming drugs [2] . It is a requirement for the successful application of the current solubility method that a solid dispersion undergoes crystallization when annealed at a pre-set temperature. Drugs falling into group I, showing crystallization during cooling from the liquid (molten) state prior to the Tg transition, may perhaps also be suitable candidates when stabilized in solid dispersions, while solubility of drugs not crystallizing during reheating (group III), cannot be assessed using the annealing approach. (Fig. 3b) . It is however certain that if crystallization occurs in a solid dispersion, it indicates its supersaturated nature in respect to the drug at a temperature this process takes place.
The endothermic sharp peak observed for crystalline and amorphous Td above 302 °C and defined for both substances as melting is shifted to lower temperatures for solid dispersions.
The reason of this is dissolving of previously crystallized Td in a polymeric matrix as a result of its increased solubility at higher temperatures. The more polymer in a solid dispersion the more shifted and blurred dissolution endotherm, which can be easily distinguished from the melting phenomenon. In the case of solid dispersions showing no crystallization, this dissolution process does not occur and thereby another endothermic event related to thermal degradation of the polymer can be seen (Fig. 3a) .
Thermal degradation of PVP-VA can be observed as the pronounced and distorted endothermic event occurring above 275 °C for the solid dispersions with the highest content of the polymer and pure polymer. Furthermore, the thermogram of crystalline Td likewise indicates its degradation above 260 °C, visible as slight lowering of the baseline (Fig. 3a) , which is confirmed by the change of powder's color from white to brown and release of smoke.
Thermogravimetric analysis carried out for both components showed 2.0% and 11.3% weight loss for Td and PVP-VA at 302 °C, respectively (Fig. 4) . Thus, thermal degradation of Td and PVP-VA, even at a heating rate of 10 °C/min, prevents the use of conventional methods for solubility assessment, which requires reliable measurements of the melting events of the drug [13, 18, 17] . 
Formation of tadalafil saturated solid dispersions
Having determined the relationship between Tgs and the composition of solid dispersions, the final protocol of solubility measurement was developed. Briefly, it assumes some crystallization of the excess of Td from the supersaturated solid dispersion and examination of
Tgs of the newly formed solid dispersion to determine its composition (Section 2.2.2.1).
Annealing at different temperatures above the crystallization onset leads to a different degree of crystallization resulting from different solubility of Td in PVP-VA. Therefore, this enables solid dispersions which are thermodynamically stable at their annealing temperatures to be obtained.
Theoretically, each Td/PVP-VA solid dispersion exhibiting crystallization upon heating, which is that with Td content ranging from 40% to 90%, could be selected for analysis. On the one hand, a high Td to PVP-VA weight ratio is desired to provide the broad solubility measurement spectrum but, from the practical point of view, the low amount of the polymer might result in a low quantity of a newly formed solid dispersion and thereby issues with Tg detection. To illustrate this, by selecting the Td/PVP-VA solid dispersions (9:1, w/w) one can determine the drug solubility ranging from 0% to 90% of Td, but in the case of low solubility the amount of a newly formed solid dispersion might constitute only slightly more than 10% of the sample weight. Indeed, crystallization of Td from solid dispersions containing less than 50% of the polymer resulted in no visible Tgs in the second heating run. Thus, the Td/PVP-VA solid dispersion (5:5, w/w) was selected for further analysis and the maximum solubility of Td in PVP-VA that could be determined was therefore 50%. Notwithstanding, as it is shown later in Section 3.1.3, higher solubility of Td in PVP-VA occurs in the range of temperatures where thermal degradation of components prevents reliable examination.
Another crucial factor affecting the results of this study is the sample annealing time, which must be long enough to enable crystallization of the entire excess of Td from the Td/PVP-VA solid dispersion (5:5, w/w). The time of annealing was optimized at the lowest accepted temperature of the process, which is at 180 °C (Fig. 6 ), as at any higher temperature the crystallization process proceeds faster due to a decrease in viscosity of the polymer. Half-hour, Table 1 . The results present significant degradation of components above 240 °C, which was additionally confirmed by the change of powder's color from white to brown. Therefore, 230 °C was selected as the upper temperature limit as confirmed by acceptably low level of degradation of Td and PVP-VA. indicates calculated solubility at 25 °C, the most common storage temperature of solid oral dosage forms, which is 20.5% (Fig. 7) . In the broad range of 0 to 200 °C the Td solubility varies by no more than 5 % but at higher temperatures it increases rapidly. At 180 °C, where the crystallization of Td starts, the solubility is 22.8% which is reflected in thermograms of solid dispersions (Figs. 3a and 3b) . The Td/PVP-VA solid dispersion (3:7, w/w) with 30% content of Td is the first for which a very broad thermal event of Td crystallization can be observed. Moreover, the phenomenon of subsequent dissolving finally finds support in the increased solubility of Td in PVP-VA in this range of temperatures.
Modified melting point depression -HSDSC
While conventional methods employed to determine solubility of drugs in polymer typically use slow heating rates [18, 17] to attain solubility equilibrium as close as practically achievable, this is not always possible especially when the drug (or polymer) is known to thermally decompose. On the other hand, by applying fast heating rates decomposition upon/after melting can be diminished or eliminated [14] . A combination of a fast heating rate, to prevent sample decomposition, with an annealing step, as previously used by Sun et al. [17] and shown to obtain solubility results comparable with those yielded using only slow heating rates and no
annealing, was applied and investigated as a novel approach to complement the method based on solid dispersions (Section 3.1.3).
The melting points of Td measured at 200 °C/min are presented in Fig. 7 (star symbols). They were fitted to the Flory-Huggins equation (Eq. (5)):
where Tm and Tm 0 are the melting points of Td in the binary mixture and pure drug respectively, ΔHfus is the heat of fusion of pure crystalline Td, ϕ is the volume fraction of Td, m is the volume ratio of PVP-VA to Td and χ is the Flory-Huggins interaction parameter.
The χ parameter was calculated to be −1.80, which indicates good miscibility of components and is in agreement with the single Tg determined for each of the solid dispersions (Fig. 3a) .
The solid-liquid line is presented in Fig. 7 (red line) and while it well described the experimental points, the extrapolated drug solubility at 25 °C was estimated at only ∼0.1%, in disagreement with the Td solubility of ∼20% as described in Section 3.1.3. This shows inadequacy of the Flory-Huggins model in relation to describing solubility of Td in PVP-VA as substantiated by stability studies (Section 3.2). A poor fit of this model was already reported by Sun et al. [17] for the mannitol/PVP system. 
Accelerated aging tests
The main goal of accelerated aging tests was to investigate physical stability of Td/PVP-VA amorphous solid dispersions with respect to the phase diagram depicted in Fig. 7 .
Thermodynamic properties resulting from the drug substance solubility in a polymer as well as kinetic properties arising from Tgs of solid dispersions are two components that are crucial in estimating the physical stability of solid dispersions. The study was carried out on nine amorphous Td/PVP-VA solid dispersions and amorphous Td so that the impact of the supersaturation degree and the Tg on the rate of crystallization could be assessed.
Neither amorphous Td nor none of the solid dispersions subjected to the aging conditions of 25 °C and 75% RH as well as 40 °C and 0% RH revealed crystallization of Td throughout the two-month study. However, the simultaneous increase in both temperature and humidity to 40 °C and 75% RH led to the physical instability of samples, as confirmed by PXRD ( Table   2) Table 2 . Crystallization behavior of amorphous tadalafil (Td) and 1:9-9:1 (w/w) Td/PVP-VA solid dispersions subjected to accelerated aging tests (40 °C and 75% RH, 80 °C and 0% RH)
analyzed after specified time intervals by PXRD.
Therefore, the crystallization tendency with regard to Td thermodynamic solubility in PVP-VA was investigated setting the humidity and temperature level to 0% and 80 °C, respectively.
In contrast to the previous study, the fastest crystallization observed after one day of storage occurred in amorphous Td and the solid dispersions with the lowest content of PVP-VA (Table   2 ). Physical instability among 3:7-6:4 (w/w) Td/PVP-VA solid dispersions was detected after two weeks (Fig. 8) , while no crystallization occurred in solid dispersions (1:9 and 2:8, w/w) even after two months of storage (Fig. 9 ). This is a strong evidence that in the absence of at 180 °C and crystallization was more pronounced in cooling the sample (Fig. 10a) . This is in agreement with the crystallization events visible in DSC thermograms (Fig. 3b) . On the contrary, no evidence of crystallization was provided while heating the 2:8 (w/w) Td/PVP-VA solid dispersion (Fig. 10b) . To investigate the physical stability of undersaturated systems above their Tgs (Fig. 7 ) Td/PVP-VA solid dispersions (1:9 and 2:8, w/w) were also stored at 130 °C and 0% RH for 2 weeks.
However, an immediate color change, from white to orange, was noticed. The change in appearance may suggest decomposition of the samples; however, they remained amorphous for the duration of this study.
Conclusions
Nine Td/PVP-VA solid dispersions varied in terms of quantitative composition (1:9-9:1, w/w)
were successfully obtained by spray-drying. Their amorphous nature, supersaturated character and molecular level of mixing (a solid solution structure) were subsequently confirmed using 
